Phase I/II study of carfilzomib, bendamustine, and dexamethasone (CBD) in patients with newly diagnosed multiple myeloma.

ABSTRACT:

SUBMITTER: Leng S 

PROVIDER: S-EPMC6997347 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature